CTX Company Description

Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.

The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics.

It has various therapeutic molecules in the preclinical stage. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.

Captor Therapeutics Spolka Akcyjna

Country	Poland
Founded	2015
Industry	Biotechnology
Sector	Healthcare
Employees	105
CEO	Thomas Shepherd

Contact Details

Address: ul. Dunska 11 Wroclaw, 54-427 Poland
Phone	48 53 786 9089
Website	captortherapeutics.com

Stock Details

Ticker Symbol	CTX
Exchange	Warsaw Stock Exchange
Fiscal Year	January - December
Reporting Currency	PLN
ISIN Number	PLCPTRT00014
SIC Code	2836

Key Executives

Name	Position
Dr. Thomas Shepherd Ph.D.	Chief Executive Officer and President of the Management Board
Sylvain Cottens	Co-Founder and Senior Vice President of Chemistry
Michal Walczak	Member of Management Board and Chief Scientific Officer
Anna Pawluk	Vice President of Operations
Marta Tomaszewska	Vice President of People and Culture
Michal Bista	Head of Structure, Fragments and Biophysics
Robert Dyjas	Head of Medical Affairs and Clinical Development